▮ Slide Shows

▮ Entertainment

Top Stories
Game of Thrones
▮ Music news
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

▮ Content Licensing

▮ Premium NEW

▮ More

Wall Street Events

Archer-Daniels-Midland Q1 22 Earnings Conference Call At 9:00 AM ET

By RTTNews Staff Writer ✉ | Published: 4/26/2022 8:01 AM ET

Archer-Daniels-Midland (ADM) will host a conference call at 9:00 AM ET on April 26, 2022, to discuss Q1 22 earnings results.

To access the live webcast, log on to https://investors.adm.com/events-and-presentations/default.aspx

For comments and feedback contact: editorial@rttnews.com

Biotech Stocks Facing FDA Decision In March 2023

Biotech Stocks Facing FDA Decision In March 2023

Biotech Stocks Facing FDA Decision In February 2023

Biotech Stocks Facing FDA Decision In February 2023

Biotech stocks Facing FDA Decision in January 2023

Biotech stocks Facing FDA Decision in January 2023

Latest Updates on COVID-19

WHO Eases Vaccination Guideline For Healthy Children And Adolescents

Biden Signs Covid Origins Bill Into Law

34% Fall In US Covid Cases, 38% Fall In Deaths In Last 2 Weeks

FDA Authorizes Bivalent Pfizer Covid Vaccine As Booster Dose For Select Children Under 5

Covid Cases, Hospitalizations Fall Nationwide In Last 2 Weeks

Read More

COVID-19: Drugs in Development

RELATED NEWS

Archer-Daniels-Midland Q4 22 Earnings Conference Call At 9:00 AM ET

Archer-Daniels-Midland Q4 Profit Increases, beats estimates

Follow RTT

Editor's Pick
Most Read
Most Emailed

Adidas To Withdraw Objection To Black Lives Matter Trademark

Generative AI Could Impact 300 Mln Jobs: Goldman Sachs

UBS Rehires Sergio Ermotti As Its CEO To Oversee Credit Suisse Merger

Jarman's Midwest Cleaning Recalls Hand Sanitizer Non-sterile Solution

Chipotle To Pay $240K To Workers After Closing Maine Store That Tried To Unionize

Lyft Co-founders To Step Down; Names David Risher CEO

Saudi National Bank Chair Al Khudairy Resigns After His Comments On Credit Suisse

Elkhorn Valley Packing Recalls Boneless Beef Chuck Products

First Citizens Bank To Buy Silicon Valley Bank's Deposits, Loans From FDIC

Pharming Stock Reaps Significant Gains After Landmark FDA Approval

Incyte Says FDA Issued CRL For Ruxolitinib Extended-release Tablets

Viking Therapeutics: Phase 1 VK2735 Clinical Trial Reports Positive Results

SoftBank Group To Acquire Berkshire Grey In $375 Mln Deal

TUI Group To Increase Capital By EUR 1.8 Bln To Repay Debt, Cut Costs

PTC Therapeutics CEO Stuart Peltz To Retire; Names Matthew Klein CEO

Micron Technology Q2 Earnings Summary

Iovance Biotherapeutics Completes BLA Submission For Lifileucel In Advanced Melanoma

Evotec Receives $6.6 Mln Grant From Bill & Melinda Gates Foundation For Drug Discovery In TB

Celyad Oncology Appoints Georges Rawadi As CEO - Quick Facts

BioNTech Q4 Profit Down On Weak Revenues; Sees FY23 COVID-19 Vaccine Revenues Of €5 Bln

Novartis : Phase III Trial Of Kisqali Combination In Early Breast Cancer Meets Primary Endpoint

DATA Communications Gets No-Objection To Buy Canadian Operations Of RRD

Walgreens Boots Alliance, Inc. Q2 Profit Decreases, but beats estimates

LyondellBasell, EEW Energy Sign LOI For Proposed Advanced Plastic Waste Sorting

Iovance Biotherapeutics Completes BLA Submission For Lifileucel In Advanced Melanoma

John Wood Group FY22 Adj. EBITDA From Cont. Ops. Flat On Last Year At Constant Currency

Salzgitter Group FY22 Profit Rises; Issues FY23 Outlook

Pitney Bowes Urges Shareholders To Vote FOR All Director Nominees, Hestia Nominee Katie May

UniFirst Q2 Profit Down; Cuts FY EPS Outlook - Quick Facts

Energy Transfer To Acquire Lotus Midstream In $1.45 Bln Deal

Hyve Group Says H1 Trading In Line With View; Sees FY23 Performance To Meet Expectations

Evotec Stock Up As It Extends Neurodegeneration Partnership With Bristol Myers Squibb

Krispy Kreme Rolls Out New Spring Minis